Tel Aviv
Israel
6
2023-10-12
5
2022-09-13
These are the the leading inventors for applications assigned to Lutris Pharma Ltd.:
Lutris Pharma Ltd. based in Tel Aviv, IL has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
USE OF TOPICAL BRAF INHIBITOR COMPOSITIONS FOR TREATMENT OF EPIDERMAL GROWTH FACTOR RECEPTOR DOWNSTREAM EFFECTORS - INDUCED CUTANEOUS REACTIONS
#2 | 2021-11-11 ✅ Patent 11,439,648 granted on 2022-09-13Use of topical BRAF inhibitor compositions for treatment of radiation dermatitis
#3 | 2021-03-11 ✅ Patent 11,339,163 granted on 2022-05-24BRaf inhibitors and use thereof for treatment of cutaneous reactions
#4 | 2020-05-14 ✅ Patent 11,197,861 granted on 2021-12-14Methods of screening BRaf inhibitors for treating cutaneous reactions
#5 | 2019-12-26 ✅ Patent 10,927,112 granted on 2021-02-23BRaf inhibitors and use thereof for treatment of cutaneous reactions
#6 | 2018-12-27 ✅ Patent 10,632,123 granted on 2020-04-28Use of BRaf inhibitors for treating cutaneous reactions
Also check out Lutris Pharma Ltd.'s (Tel Aviv, Israel) applicant profile with 6 patent applications submitted.
342470 ⎘